BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 16441824)

  • 1. Hypovitaminosis D masking hypercalcemia in primary hyperparathyroidism: case report.
    Elsherbiny TM
    Ther Adv Endocrinol Metab; 2023; 14():20420188231213208. PubMed ID: 38028332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-alkali syndrome as a rare cause of severe hypercalcemia requiring dialysis in early twin gestation.
    Beamish P; Mansour C; Druce I; O'Meara P
    Obstet Med; 2024 Jun; 17(2):116-118. PubMed ID: 38784190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation Treatment for Inoperable Local Relapse of Parathyroid Carcinoma With Symptomatic Hypercalcemia: A Case Report.
    Bollen H; Decallonne B; Nuyts S
    Front Oncol; 2021; 11():733772. PubMed ID: 34900684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Symptomatic Hypocalcemia, complicating cardiac arrhythmia following Cinacalcet (Sensipar
    Schmidt GS; Weaver TD; Hoang TD; Shakir MKM
    Clin Case Rep; 2021 Oct; 9(10):e04876. PubMed ID: 34659755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 54-year-old man with gout-induced immobilization hypercalcemia.
    Lin N; Chen Y; Xu L
    Ther Apher Dial; 2024 Apr; 28(2):331-332. PubMed ID: 38010058
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.
    Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P
    Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
    Moe SM; Cunningham J; Bommer J; Adler S; Rosansky SJ; Urena-Torres P; Albizem MB; Guo MD; Zani VJ; Goodman WG; Sprague SM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2186-93. PubMed ID: 16030053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking at calcimimetics impact on hypercalcemia of immobilization: hypotheses and a case study.
    Roueff S; Saint Georges M; Chuong VT; Abbassi A; Guédon C; de Vernejoul MC; Ureña Torres P
    Hemodial Int; 2006 Jan; 10(1):29-34. PubMed ID: 16441824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.